nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—chronic kidney failure	0.677	0.731	CbGaD
Levetiracetam—ABCB1—chronic kidney failure	0.249	0.269	CbGaD
Levetiracetam—ABCC2—Codeine and Morphine Metabolism—ABCC3—chronic kidney failure	0.00412	0.0561	CbGpPWpGaD
Levetiracetam—ABCB1—Abacavir transmembrane transport—SLC22A2—chronic kidney failure	0.004	0.0545	CbGpPWpGaD
Levetiracetam—ABCC2—Codeine and Morphine Metabolism—CYP3A4—chronic kidney failure	0.00259	0.0352	CbGpPWpGaD
Levetiracetam—ABCB1—Abacavir transport and metabolism—SLC22A2—chronic kidney failure	0.0023	0.0313	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—ABCC3—chronic kidney failure	0.00225	0.0307	CbGpPWpGaD
Levetiracetam—ABCC2—Codeine and Morphine Metabolism—ABCB1—chronic kidney failure	0.00209	0.0285	CbGpPWpGaD
Levetiracetam—ABCB1—Codeine and Morphine Metabolism—ABCC3—chronic kidney failure	0.00194	0.0264	CbGpPWpGaD
Levetiracetam—ABCB1—Codeine and Morphine Metabolism—ABCC2—chronic kidney failure	0.00186	0.0253	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.00171	0.0233	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—SLC22A2—chronic kidney failure	0.00166	0.0226	CbGpPWpGaD
Levetiracetam—ABCC2—Irinotecan Pathway—CYP3A4—chronic kidney failure	0.00165	0.0225	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKD1—chronic kidney failure	0.00163	0.0223	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCG1—chronic kidney failure	0.00163	0.0222	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—CYP2B6—chronic kidney failure	0.0015	0.0205	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.00143	0.0195	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—SLC6A13—chronic kidney failure	0.00142	0.0194	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—chronic kidney failure	0.00142	0.0193	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—ABCC3—chronic kidney failure	0.00136	0.0185	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.00129	0.0176	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—SLC22A2—chronic kidney failure	0.00127	0.0173	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCC3—chronic kidney failure	0.00124	0.0168	CbGpPWpGaD
Levetiracetam—ABCB1—Codeine and Morphine Metabolism—CYP3A4—chronic kidney failure	0.00122	0.0166	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—chronic kidney failure	0.00115	0.0156	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—SLC6A13—chronic kidney failure	0.00109	0.0148	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C19—chronic kidney failure	0.00108	0.0147	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—chronic kidney failure	0.00106	0.0144	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—chronic kidney failure	0.00102	0.0138	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—chronic kidney failure	0.000853	0.0116	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.000813	0.0111	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.000802	0.0109	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000799	0.0109	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCG1—chronic kidney failure	0.000767	0.0104	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—chronic kidney failure	0.000706	0.00962	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—chronic kidney failure	0.000691	0.00941	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.000672	0.00916	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—chronic kidney failure	0.000665	0.00907	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.000658	0.00897	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—chronic kidney failure	0.000638	0.0087	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCB1—chronic kidney failure	0.000629	0.00857	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—chronic kidney failure	0.000612	0.00834	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.000608	0.00829	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.000583	0.00795	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCC3—chronic kidney failure	0.000581	0.00792	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TFDP2—chronic kidney failure	0.000575	0.00783	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIP5K1B—chronic kidney failure	0.000562	0.00766	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCC2—chronic kidney failure	0.000557	0.00759	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000554	0.00755	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—chronic kidney failure	0.000507	0.00691	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC6A13—chronic kidney failure	0.000491	0.00669	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—KEAP1—chronic kidney failure	0.000446	0.00607	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GCKR—chronic kidney failure	0.000435	0.00593	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LRP2—chronic kidney failure	0.000417	0.00569	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—ABCC3—chronic kidney failure	0.000403	0.00549	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—chronic kidney failure	0.000401	0.00547	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CYBB—chronic kidney failure	0.000388	0.00529	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.000382	0.00521	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000376	0.00512	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CST3—chronic kidney failure	0.000368	0.00501	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF23—chronic kidney failure	0.000368	0.00501	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NCF1—chronic kidney failure	0.00032	0.00436	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—chronic kidney failure	0.000317	0.00433	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CYBA—chronic kidney failure	0.000301	0.0041	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FASN—chronic kidney failure	0.000295	0.00403	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS1—chronic kidney failure	0.000277	0.00377	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HBEGF—chronic kidney failure	0.000264	0.0036	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.00026	0.00355	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EPO—chronic kidney failure	0.00025	0.00341	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—HBEGF—chronic kidney failure	0.000244	0.00333	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	0.000215	0.00294	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LPL—chronic kidney failure	0.000211	0.00288	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CCR5—chronic kidney failure	0.000195	0.00265	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTHFR—chronic kidney failure	0.00019	0.00259	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	0.000183	0.0025	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic kidney failure	0.000179	0.00244	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	0.000179	0.00243	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	0.00017	0.00232	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IRS1—chronic kidney failure	0.000158	0.00215	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	0.000157	0.00214	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SERPINE1—chronic kidney failure	0.000139	0.00189	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS3—chronic kidney failure	0.000133	0.00181	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	0.000129	0.00176	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GCKR—chronic kidney failure	0.000129	0.00176	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—chronic kidney failure	0.000129	0.00176	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—chronic kidney failure	0.000121	0.00165	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic kidney failure	0.000114	0.00155	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC34A1—chronic kidney failure	0.000101	0.00138	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—chronic kidney failure	8.77e-05	0.00119	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC22A2—chronic kidney failure	8.62e-05	0.00117	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC7A9—chronic kidney failure	8.4e-05	0.00114	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KRAS—chronic kidney failure	8.12e-05	0.00111	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—chronic kidney failure	8.11e-05	0.00111	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—chronic kidney failure	8.03e-05	0.00109	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG1—chronic kidney failure	8.01e-05	0.00109	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic kidney failure	7.85e-05	0.00107	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC6A13—chronic kidney failure	7.39e-05	0.00101	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—chronic kidney failure	6.79e-05	0.000926	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—AVP—chronic kidney failure	6.78e-05	0.000924	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—chronic kidney failure	6.61e-05	0.0009	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	6.57e-05	0.000895	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—chronic kidney failure	6.24e-05	0.00085	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	6.07e-05	0.000827	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	6.07e-05	0.000827	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—chronic kidney failure	5.82e-05	0.000794	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	5.82e-05	0.000793	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	5.53e-05	0.000753	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FABP1—chronic kidney failure	5.47e-05	0.000746	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AGXT—chronic kidney failure	5.19e-05	0.000707	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GATM—chronic kidney failure	5.19e-05	0.000707	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	5.13e-05	0.0007	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACAT1—chronic kidney failure	4.75e-05	0.000647	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MLXIPL—chronic kidney failure	4.41e-05	0.000601	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	4.26e-05	0.00058	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—chronic kidney failure	4.11e-05	0.00056	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC22A2—chronic kidney failure	4.04e-05	0.00055	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG1—chronic kidney failure	3.75e-05	0.000511	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	3.69e-05	0.000503	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	3.67e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ARG2—chronic kidney failure	3.6e-05	0.00049	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LCAT—chronic kidney failure	3.53e-05	0.000481	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	3.35e-05	0.000457	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—DDC—chronic kidney failure	3.24e-05	0.000441	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	3.19e-05	0.000435	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PRKAG2—chronic kidney failure	3.14e-05	0.000428	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2B6—chronic kidney failure	3.14e-05	0.000428	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PRKD1—chronic kidney failure	3.14e-05	0.000428	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	3.08e-05	0.000419	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SREBF2—chronic kidney failure	2.94e-05	0.000401	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	2.87e-05	0.000392	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	2.85e-05	0.000388	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCC3—chronic kidney failure	2.84e-05	0.000387	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCKR—chronic kidney failure	2.84e-05	0.000387	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPIN1—chronic kidney failure	2.78e-05	0.000379	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2C18—chronic kidney failure	2.73e-05	0.000371	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LRP2—chronic kidney failure	2.73e-05	0.000371	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	2.6e-05	0.000354	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CPT1A—chronic kidney failure	2.32e-05	0.000316	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2C19—chronic kidney failure	2.26e-05	0.000308	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LIPC—chronic kidney failure	2.26e-05	0.000308	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SCARB1—chronic kidney failure	2.09e-05	0.000284	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS1—chronic kidney failure	2.07e-05	0.000282	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SREBF1—chronic kidney failure	2.03e-05	0.000276	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMGCR—chronic kidney failure	1.97e-05	0.000269	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.93e-05	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FASN—chronic kidney failure	1.93e-05	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP3A4—chronic kidney failure	1.79e-05	0.000243	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCA1—chronic kidney failure	1.76e-05	0.000239	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAT—chronic kidney failure	1.49e-05	0.000203	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPL—chronic kidney failure	1.38e-05	0.000188	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1A1—chronic kidney failure	1.33e-05	0.000181	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—chronic kidney failure	1.24e-05	0.000169	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARA—chronic kidney failure	1.22e-05	0.000166	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—POMC—chronic kidney failure	9.92e-06	0.000135	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—chronic kidney failure	9.05e-06	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NOS3—chronic kidney failure	8.65e-06	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—chronic kidney failure	7.92e-06	0.000108	CbGpPWpGaD
